$OPRX OptimizeRx Corp Insider Trading
Get free email notifications about insider trading in OptimizeRx Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in OptimizeRx Corp. Insider overview, share value development, latest insider transactions and email notifications about new events in OptimizeRx Corp for free.
CIK Number: 0001448431
IRS Number: 261265381
Industry: SERVICES-BUSINESS SERVICES, NEC [7389]
Trading Symbol: OPRX
Company Address: 400 WATER ST., STE. 200 ROCHESTER 48307
Phone number: 248-651-6568
Former name: RFID Ltd
Market Capitalization: $22.85M
Prev close: $0.74
Average Daily Volume: 26,750
Days Low: $0.73
Year Low: $0.65
Year High: $1.20
OptimizeRx Corp Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 02 2021 | OPRX | OptimizeRx Corp | WASSON GREGORY D | Director | Grant | A | 0.00 | 539 | 0 | 17,524 | 17 K to 17.5 K (+3.17 %) |
Apr 02 2021 | OPRX | OptimizeRx Corp | Vos Ellen O'Connor | Director | Grant | A | 0.00 | 539 | 0 | 32,483 | 31.9 K to 32.5 K (+1.69 %) |
Apr 02 2021 | OPRX | OptimizeRx Corp | Spangler Patrick D | Director | Grant | A | 0.00 | 539 | 0 | 21,928 | 21.4 K to 21.9 K (+2.52 %) |
Apr 02 2021 | OPRX | OptimizeRx Corp | Lang James Paul | Director | Grant | A | 0.00 | 539 | 0 | 32,253 | 31.7 K to 32.3 K (+1.70 %) |
Apr 02 2021 | OPRX | OptimizeRx Corp | HALAS GUS D | Director | Grant | A | 0.00 | 539 | 0 | 64,421 | 63.9 K to 64.4 K (+0.84 %) |
Mar 26 2021 | OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CHIEF EXECUTIVE OFF ... | Option Exercise | M | 3.21 | 394,739 | 1,267,112 | 0 | |
Mar 26 2021 | OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CHIEF EXECUTIVE OFF ... | Payment of Exercise | F | 47.44 | 26,710 | 1,267,122 | 561,307 | 588 K to 561.3 K (-4.54 %) |
Mar 26 2021 | OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CHIEF EXECUTIVE OFF ... | Buy | M | 3.21 | 394,739 | 1,267,112 | 588,017 | 193.3 K to 588 K (+204.23 %) |
Mar 26 2021 | OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CHIEF EXECUTIVE OFF ... | Sell | S | 46.10 | 80,000 | 3,688,000 | 193,278 | 273.3 K to 193.3 K (-29.27 %) |
Mar 26 2021 | OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CHIEF EXECUTIVE OFF ... | Sell | S | 50.50 | 20,000 | 1,010,000 | 273,278 | 293.3 K to 273.3 K (-6.82 %) |
Jan 29 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 7.51 | 4,315 | 32,406 | 107,134 | |
Jan 29 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Buy | M | 7.51 | 4,315 | 32,406 | 90,217 | 85.9 K to 90.2 K (+5.02 %) |
Jan 29 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Sell | S | 47.25 | 5,032 | 237,762 | 85,902 | 90.9 K to 85.9 K (-5.53 %) |
Jan 29 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 7.51 | 4,315 | 32,406 | 107,134 | |
Jan 29 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Buy | M | 7.51 | 4,315 | 32,406 | 90,217 | 85.9 K to 90.2 K (+5.02 %) |